Trendingnow
Tech

By Norah Rami, Matthew Griffin and BloombergAugust 29, 2026

Forget GLP-1 stocks, baldness drugs are Wall Street’s next goldmine
By Avalon Pernell, Lisa Pham and BloombergAugust 29, 2026


By Sasha RogelbergAugust 28, 2026

By Kaitlyn Huamani and The Associated PressAugust 28, 2026

By Kamal AhmedAugust 27, 2026

By Catherina GioinoAugust 28, 2026
Latest stories from Fortune
More TechPage 43 of 100

By Eva Roytburg, Joey Cappelletti, Hannah Schoenbaum and The Associated PressJune 10, 2026

By Sharon GoldmanJune 10, 2026

By Jacqueline MunisJune 10, 2026

By Preston ForeJune 10, 2026

By Emma BurleighJune 10, 2026

By Jacqueline MunisJune 10, 2026

By Nick LichtenbergJune 10, 2026

By Ben WeissJune 10, 2026

By Lily Mae LazarusJune 10, 2026

By Sasha RogelbergJune 10, 2026

By Shawn TullyJune 10, 2026

By Angelica AngJune 10, 2026

By Amanda GerutJune 9, 2026

By Eva RoytburgJune 9, 2026

By Sharon GoldmanJune 9, 2026

By Nick LichtenbergJune 9, 2026

By Jordan BlumJune 9, 2026

By Sharon GoldmanJune 9, 2026

By Sebastian HerreraJune 9, 2026

By Beatrice NolanJune 9, 2026

By Stan Choe and The Associated PressJune 9, 2026

By Amanda GerutJune 9, 2026

By Sebastian HerreraJune 9, 2026

By Jeff John RobertsJune 9, 2026
Most Popular























